Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,447,373
-$132,751 QoQ
Shares Held
8,130
+4.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#304
of 780 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF NOVA SCOTIA holds $233,247,691 across 19 Biotechnology names. ALNY ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
181,706 | $113,300,959 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
1,238,830 | $43,842,193 | |
| 3 | EXEL |
Exelixis, Inc.
|
419,730 | $22,837,509 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
73,879 | $13,836,059 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,607 | $13,713,225 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
133,805 | $10,906,445 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
68,548 | $5,435,170 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
8,130 | $2,447,373 |
All Filings in ALNY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,447,373 | 8,130 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,580,124 | 7,798 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,081,389 | 7,749 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,710,464 | 5,944 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $873,595 | 2,679 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,216,710 | 4,506 | Shares | Sole | 2025-07-02 | |
| 2024-12-31 | $1,061,718 | 4,512 | Shares | Sole | 2025-07-02 | |
| 2024-09-30 | $1,783,019 | 6,483 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,612,062 | 6,634 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,997,100 | 13,363 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,153,245 | 6,025 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $522,090 | 2,948 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $473,140 | 2,491 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $651,240 | 3,251 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,048,274 | 4,411 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $681,945 | 3,407 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $378,334 | 2,594 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,169,646 | 7,163 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $248,265 | 1,464 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $439,100 | 3,110 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $571,997 | 4,401 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $619,528 | 4,255 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $553,931 | 3,740 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||